Chapter 4 Flashcards
Psychopharmacology
The study of the effects of drugs on the nervous system and behavior
Drugs
An exogenous chemical not necessary for normal cellular functioning that significantly alters the functions of certain cells of the body when taken in relatively low doses
Drug effects
Observable changes in and individual’s physiology and /or behavior
Sites of action
The locations where drug molecules interact with molecules on or in cells to affect biochemical processes
Pharmacokinetics
The process by which drugs are absorbed, distributed within the body, metabolized and excreted
Intravenous injection (IV)
Injection of a substance directly into a vain.
Intraperitoneal injection (IP)
Injection of a substance into the peritoneal cavity - the space that surrounds the stomach, intestines, liver, and other abdominal organs
Intramuscular injection (IM)
Injection of a substance into a muscle
Subcutaneous injection (SC)
Injection of a substance into the space beneath the skin.
Oral administration
Administration of a substance into the mouth so that it is swallowed.
Sublingual administration
Administration of a substance by placing it beneath the tongue
Inhalation
Administration of a vaporous substance into the lungs
Topical administration
Administration of a substance directly onto the skin or mucous membrane
Insufflation
Administration of a substance by sniffing or snorting; drug is absorbed through the mucous membranes of the nose
Lipid solubility
The ability of fat-based molecules to pass through cell membranes
Dose-response curve
A graph of the magnitude of an effect of a drug as a function of the amount of drug administered
Therapeutic index
The ratio between the dose that produces the desired effect in 50 percent of the animals and the dose that produces toxic effects in 50 percent of the animals
Affinity
The readiness with which two molecules join together
Tolerance
A decrease in the effectiveness of a drug that is administered repeatedly
Sensitization
An increase in the effectiveness of a drug that is administered repeatedly
Withdrawal symptoms
The appearance of symptoms opposite to those produced by a drug when the drug is administered repeatedly and then suddenly no longer taken
Physical dependence
Compensatory changes following repeated use of a drug that result in withdrawal symptoms when the drug is no longer taken.
Placebo
An inert substance that is given to an organism in lieu of a physiologically active drug; used experimentally to control for the effects of mere administration of a drug
Antagonist
A drug that opposes or inhibits the effects of a particular neurotransmitter on the postsynaptic cell
Agonist
A drug that facilitates the effects of a particular neurotransmitter on the postsynaptic cell
Direct agonist
A drug that binds with and activates a receptor
Receptor blocker
A drug that binds with a receptor but does not activate it; prevents the natural ligand from binding with the receptor
Direct antagonist
A synonym for receptor blocker
Noncompetitive binding
Binding of a drug to a site on a receptor; does not interfere with the binding sure for the principal ligand
Indirect antagonist
A drug that attaches to a binding site on a receptor and interferes with the action of the receptor; does not interfere with the binding site for the principal ligand
Indirect agonist
A drug that attaches to a binding site on a receptor and facilitates the actions of the receptor; does not interfere with the binding site for the principal ligand
Glutamate
An amino acid; the most Important excitatory neurotransmitter in the brain
Vesicle glutamate transporter
Proteins in the vesicles membrane that pumps glutamate into a vesicle
NMDA receptor
A specialized ionotropic glutamate receptor that controls a calcium channel that is normally blocked by Mg2+ ions; has several other binding sites
AMPA receptor
An ionotropic glutamate receptor that controls a sodium channel; stimulated by AMPA
Kainate receptor
An ionotropic glutamate receptor that controls a sodium channel; stimulated by kainic acid
Metabotropic glutamate receptor
A category of metabotropic receptors that are sensitive to glutamate
PCP
Phencyclidine; a drug that binds with the PCP binding site of the NMDA receptor and serves as an indirect antagonist
Ketamine
A drug that binds with a noncompetitive binding site of the NMDA receptor and serves as an indirect antagonist
Excitatory amino acid transporters
Proteins that remove glutamate and other excitatory amino acids from the synapse
Glutamate synthase
Enzyme that breaks down glutamate into its precursor glutamate
Glutamate excitotoxcity
Toxic overstimulation of the postsynaptic cell by excess glutamate
GABA
An amino acid; the most important inhibitory neurotransmitter in the Brain
Vesicle GABA transporter
Proteins in the vesicle membrane that pump GABA into a vesicle
GABA transporter
Proteins that remove GABA from the synapse
Choline acetyltransferase
The enzyme that transfers the acetate ion from acetyl coenzyme A to choline, producing the neurotransmitter acetylcholine
Vesicle ACh transporter
Proteins in the vesicle membrane that pump acetylcholine into a vesicle
Botulinum toxin
An acetylcholine antagonist; prevents release by terminal buttons
Nicotine
An agonist for the ionotropic acetylcholine receptor
Muscarine
An agonist for the metabotropic acetylcholine receptor
Neostigmine
A drug that inhibits the activity of acetylcholine
Monoamine
A class of amines that includes indolamines, such as serotonin and catecholamines such as dopamine, norepinephrine and epinephrine
Catecholamine
A class of amines that includes the neurotransmitters dopamine, norepinephrine, and epinephrine
Dopamine
A neurotransmitter; one of the catecholamines; important in movement , attention, learning, and reinforcing effects of drugs that people tend to abuse
Nigrostriatal system
A system of neurons originating in the substantia nigra and terminating in the neostriatum; controls movement
Mesolimbic system
A system of dopaminergic neurons originating in the ventral regimental area and terminating in the nucleus accumbens, amygdala, and hippocampus; effects reinforcement (rewards)
Mesocortial system
A system of dopaminergic neurons neurons originating in the ventral tegmental area and terminating in the prefrontal cortex; effects short term memory, planning, strategies for problem solving
Parkinson’s disease
A neurological disease characterized by tremors, rigidity of the limbs, poor balance, and difficulty in initiating movements; caused by degeneration of the nigrostriatal system
L-DOPA
The levorotatory form of DOPA; the precursor of catecholamines; often used to treat Parkinson’s disease because of its effect as a dopamine agonist
Vesicle monoamine transporter
Proteins in the vesicle membrane that pump monoamine neurotransmitter into a vesicle
Apomorphine
A drug that blocks dopamine auto receptor at low doses; at higher doses, block post synaptic receptors as well.
Dopamine transporter
Proteins that remove dopamine from the synapse
Amphetamine
An antagonist at dopamine and norepinephrine transporters that causes them to run in reverse releasing these neurotransmitters into the synapse
Methamphetamine
An antagonist at dopamine and norepinephrine transporters that cause them to run in reverse, releasing these neurotransmitters into the synapse
Cocaine
A drug that inhibits the reputake of dopamine
Methylphenidate
A drug that inhibits the reuptake of dopamine
Monoamine oxidase
A class of enzymes that destroy the monoamine; dopamine, norepinephrine and serotonin
Norepinephrine
One of the catecholamines; a neurotransmitter found in the brain and in the sympathetic division of the autonomic nervous system
Epinephrine
One of the catecholamines; a hormone secreted by the adrenal medulla; serves also a neurotransmitter in the brain
Locus coeruleus
A dark colored group of noradrenergic cell bodies located in the pond near the Rostral end of the floor of the fourth ventricle
Axonal varicosity
An enlarged region along the length of an axon that contains synaptic vesicles and releases a neurotransmitter or neuromodulator
Norepinephrine transporters
Proteins that remove norepinephrine from the synapse
Serotonin
An indolamine neurotransmitter also called 5- hydroxytryptamine; controls mood, eating, sleep, and arousal, and regulation of pain; can also control dreaming
Serotonin transporter
Proteins that remove serotonin from the synapse
Fluoxetine
A drug that inhibits the reuptake of 5-HT (serotonin)
MDMA
A drug that serves as a noradrenergic and serotonergic agonist also known as ecstasy has excitatory and hallucinogenic effects
Histamine
A neurotransmitter that plays an important role in stimulating wakefulness
Diphenhydramine
An antihistamine drug; antagonist at histamine receptors
Endogenous opioid
A class of peptides secreted by the brain that act as opiates
Opium
Agonist for opiate receptor
Morphine
Agonist for opiate receptor
Oxycodone
An agonist for opiate receptor
Enkephalins
One of the endogenous opioids
Methadone
Agonist for opiate receptor
Naloxone
A drug that blocks opiate receptors
Endocannabidoid
A lipid; an endogenous ligand for cannabidoid receptors which also bind with THC the active ingredient in marijuana
THC
The active ingredient in marijuana activates CB1 receptors in The brain
Anandamide
The first cannabidoid to be discovered and probably the most important one